OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells is a paramount challenge with the biopharmaceutical industry. Multiple strategies can be employed enhance antibody titer, comprising process parameter optimization, media optimization, and the use of perfusion technologies. Fine-tuning culture conditions